Q3 2017 Holdings
Filed 2017-11-14 | 16 holdings | $4.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anavex Life Sciences Corp(AVXL) | COM NEW | 032797300 | $3.0M | 724,205 | 74.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $893.0K | 124,096 | 22.3% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $40.2K | 2,359,767 | 1.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $30.2K | 807,224 | 0.8% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $26.7K | 3,738,925 | 0.7% |
| Vascular Biogenics LTD | COM | M96883109 | $5.3K | 860,605 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.0K | 300,000 | 0.1% |
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | $1.6K | 2,595,484 | 0.0% |
| Keryx Biopharmaceuticals Inc. | COM | 492515101 | $1.4K | 200,000 | 0.0% |
| Volition RX LTD(VNRX) | COM | 928661107 | $1.2K | 461,538 | 0.0% |
| Summit Therapeutics PLC | SPONS ADS | 86627R102 | $1.2K | 91,800 | 0.0% |
| Alcobra Ltd | SHS | M2239P109 | $812 | 804,049 | 0.0% |
| Evoke Pharma Inc | COM | 30049G104 | $752 | 225,000 | 0.0% |
| Caladrius Biosciences Inc(NBSEUR) | COM NEW | 128058203 | $422 | 117,957 | 0.0% |
| Advaxis Inc. | W EXP 07/15/201 | 007624117 | $191 | 112,500 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $99 | 25,000 | 0.0% |